Abstract:Objective: This study was designed to investigate the value of nano-MRI compared with the routine gadolinium diethylene triaminepenta acetate contrast MRI of metastatic hepatocellular carcinoma. Methods: Livers of healthy BALB/c nude mice were implanted with cells of hepatocellular carcinoma - HepG2 and SMMC77219, respectively. Small interfering RNA targeting was accomplished against one of the three hepatocellular carcinoma-survivin gene sequences. Nanometer grade particles especially the superparamagnetic iron oxide nanoparticle superparamagnetic iron oxide nanoparticles Resovist was complexed with polylysine and siRNA designed specifically to create an enhanced contrast agent with superparamagnetic iron oxide nanoparticles. Both hepatocellular carcinoma - HepG2 and SMMC7721 groups were scanned at 1.5 T MRI without any contrast MRI, gadolinium diethylene triaminepenta acetate contrast medium, and the specific enhanced contrast agent with superparamagnetic iron oxide nanoparticles by injecting the contrast media via tail vein. All mice were scanned with T2 weighted imaging 24 h post-injection, to observe the effect of the specific contrast medium with superparamagnetic iron oxide nanoparticles. Subsequently, all the mice were sacrificed to extract the livers. Results: Tumor detection rate 24 h post-injection, corresponding to the specific contrast agent with superparamagnetic iron oxide nanoparticles showed a significant difference compared with the gadolinium diethylene triaminepenta acetate contrast agent. The livers still showed remarkably low signal change within the signal enhanced region of T2WI compared with instant imaging using the specific SPIO. Conclusion: Nanometer grade particles can be stably transfected into tumor cells to facilitate detection of human hepatocellular carcinoma xenografts in nude mice using small interfering RNA. The strong paramagnetic effect observed with the high valence iron in T2WI improves the detection rate of micronodular (< 5 mm) HCC with MRI.

Chiral Ultrasmall Nickel Hydroxide Nanoparticles Enable Enantioselective Magnetic Resonance Imaging of Hepatocellular Carcinoma and Lung Metastases

Chiral Iron Oxide Supraparticles Enable Enantiomer‐dependent Tumor‐Targeted Magnetic Resonance Imaging

Nanoparticle-based MRI of metastatic human hepatocellular carcinoma: Targeting survivin gene with siRNA in an animal model

SPIO-Loaded Nanostructured Lipid Carriers for T2-weighted Magnetic Resonance Imaging of Hepatocarcinoma

A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging

Highly Sensitive Diagnosis of Small Hepatocellular Carcinoma Using Ph-Responsive Iron Oxide Nanocluster Assemblies.

Using PEGylated Iron Oxide Nanoparticles with Ultrahigh Relaxivity for MR Imaging of an Orthotopic Model of Human Hepatocellular Carcinoma

Gadolinium-loaded Calcium Phosphate Nanoparticles for Magnetic Resonance Imaging of Orthotopic Hepatocarcinoma and Primary Hepatocellular Carcinoma.

Hyaluronic Acid-Modified Manganese-Chelated Dendrimer-Entrapped Gold Nanoparticles for the Targeted CT/MR Dual-Mode Imaging of Hepatocellular Carcinoma

Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatment

Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An in vitro and in vivo Study.

In Vitro and in Vivo Magnetic Resonance Imaging with Chlorotoxin-Conjugated Superparamagnetic Nanoprobes for Targeting Hepatocarcinoma.

Novel Nanovectors As Liver Targeting MRI Contrast Agents

Glutathione-Responsive Magnetic Nanoparticles for Highly Sensitive Diagnosis of Liver Metastases.

Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis

Chirality of Copper-Amino Acid Nanoparticles Determines Chemodynamic Cancer Therapeutic Outcome

Superparamagnetic Nanocrystals Clustered Using Poly(ethylene glycol)-Crosslinked Amphiphilic Copolymers for the Diagnosis of Liver Cancer

An NIR-II/MR dual modal nanoprobe for liver cancer imaging

Synthesis and Application of Strawberry-Like Fe3O4-Au Nanoparticles As CT-MR Dual-Modality Contrast Agents in Accurate Detection of the Progressive Liver Disease.

Manganese (II) Chelate Functionalized Copper Sulfide Nanoparticles for Efficient Magnetic Resonance/Photoacoustic Dual-Modal Imaging Guided Photothermal Therapy.

SPION@Cu2-xS Nanoclusters for Highly Sensitive MRI and Targeted Photothermal Therapy of Hepatocellular Carcinoma.